Evidence map›Paper›PMID 42587049›Full record

ArticleNature biomedical engineering2026

Deep-learning triage of three-dimensional pathology datasets for comprehensive and efficient pathologist assessments.

Gan Gao, Renao Yan, Andrew H Song, Huai-Ching Hsieh, Lindsey A Erion Barner, Fiona Wang, David Brenes, Sarah S L Chow, Rui Wang, Kevin W Bishop and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Prototype-based AI triage for 3D pathology.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Gan GaoDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Renao Yan *Department of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Andrew H Song *Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9356-9156
Huai-Ching HsiehDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Lindsey A Erion BarnerDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Fiona WangDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
David BrenesDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Sarah S L ChowDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.
Rui WangDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0009-0007-6553-2074
Kevin W BishopDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-8722-6464
Yongjun LiuDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Xavier FarrePublic Health Agency of Catalonia, Lleida, Spain.ORCID http://orcid.org/0000-0001-8702-4643
Mukul DivatiaDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Michelle R DownesDivision of Anatomic Pathology, Department of Laboratory Medicine and Molecular Diagnostics, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Laboratory Medicine and Pathobiology, Toronto, Ontario, Canada.
Funda Vakar-LopezDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Priti LalPathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Wynn BurkeDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-0165-6154
Anant MadabhushiWallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-5741-0399
Lawrence D TrueDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8621-9569
Deepti M ReddiDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
William M GradyDepartment of Medicine, University of Washington, Seattle, WA, USA.
Faisal MahmoodDepartment of Pathology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7587-1562
Jonathan T C LiuDepartment of Mechanical Engineering, University of Washington, Seattle, WA, USA. jonliu@stanford.edu.ORCID http://orcid.org/0000-0001-5650-3086

Funding

Prostate cancer risk stratification via computational 3D pathologyR01CA268207 · NCI · UNIVERSITY OF WASHINGTON · PI Jonathan T.C. Liu, Anant Madabhushi · 2022 to 2026
$3.1M
Computational 3D pathology for Barrett's esophagus risk stratificationR01DK138948 · NIDDK · UNIVERSITY OF WASHINGTON · PI William Mallory Grady, Jonathan T.C. Liu · 2024 to 2026
$2.2M
Instrumentation platform for 3D pathology with open-top light-sheet microscopyR01EB031002 · NIBIB · UNIVERSITY OF WASHINGTON · PI LIU, JONATHAN T.C. · 2021 to 2024
$1.9M
National Science Foundation (NSF) DGE-1762114ODNI | Intelligence Advanced Research Projects Activity (IARPA) D24AC00357ODNI | Intelligence Advanced Research Projects Activity (IARPA) D25AC00140U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA268207U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) R01EB031002U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK138948
6 · The paper itself

Abstract

Standard slide-based two-dimensional (2D) histopathology severely undersamples spatially heterogeneous tissue, with each thin 2D section representing <1% of the entire biopsy volume. Recent advances in non-destructive three-dimensional (3D) pathology, such as open-top light-sheet microscopy, enable comprehensive high-resolution imaging of large clinical specimens. Since manual review of these massive and complex 3D datasets is infeasible in clinical practice, we present TRICARE, a deep-learning triage framework that identifies high-risk 2D cross sections within 3D pathology datasets to enable time-efficient pathologist evaluation, which offers a lower-risk route for accelerated adoption by retaining pathologists for final diagnoses. TRICARE assigns risk scores to all 2D levels within a tissue volume by leveraging context from a subset of neighbouring depth levels, outperforming models in which predictions are based on isolated 2D levels. In two use cases-risk stratification based on prostate cancer biopsies and screening for dysplasia/cancer in endoscopic biopsies of Barrett's esophagus-AI-triaged 3D pathology, enabled by TRICARE, demonstrates the potential to improve the detection of high-risk diseases compared with slide-based 2D histopathology while optimizing pathologist workloads.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.